Nycomed Amersham PLC

Pharmaceuticals
United Kingdom
Revenue (US$ Millions)$1,920
Revenue Growth (%)-24.96%
Net Income (US$ Millions)$148
Earnings Per Share (US$)$0.23
Total Equity (US$ Millions)$568
Profit Margin (%)7.71%
Debt To Equity Ratio (%)1.15%